MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517042890 A) filed by Institute Of Materia Medica, Chinese Academy Of Medical Sciences, Beijing, on May 2, for 'keratin yk93-6, preparation method therefor, pharmaceutical composition thereof, and use thereof.'
Inventor(s) include Yu, Shishan; Chen, Xiaoguang.; Jin, Jing; Li, Mi; Shi, Guoru; Liu, Yunbao; Wang, Xiaojing; Jiang, Huimin; Li, Yong; Qu, Jing; Hao, Mengyao; Wang, Mingjin; Ma, Shuanggang; Su, Guozhu; Li, Shuying; and Fu, Jiang.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "The present invention pertains to the field of biopharmaceuticals and provides a keratin YK93-6, a nucleic acid molecule encoding same, an expression vector comprising the nucleic acid molecule, a host cell that contains the expression vector or whose genome is integrated with the nucleic acid molecule, a preparation method therefor, and a pharmaceutical composition thereof. The present invention also provides use of the described keratin YK93-6 among other products in the preparation of medicaments for treating prostatic hyperplasia, lymphoma, melanoma, pain, lactation disorders, breast cancer, lung cancer, hysteromyoma, coagulation disorders, and the like."
The patent application was internationally filed on Sept. 26, 2023, under International application No.PCT/CN2023/121364.
Disclaimer: Curated by HT Syndication.
